State Stem Cell Agency Grants Working Group Agenda 2/9/09

Day 1
Feb 9, 2009
Main Location: 

Westin on Market
50 Third Street
San Francisco, CA

Day 2
Feb 10, 2009
Main Location: 

Westin on Market
50 Third Street
San Francisco, CA

Day 3
Feb 11, 2009
Main Location: 

Westin on Market
50 Third Street
San Francisco, CA

 

 

 

 

 

 

 

 

California State Stem Cell Agency

 

REGULAR MEETING OF THE SCIENTIFIC AND MEDICAL

REGULAR MEETING OF THE
SCIENTIFIC AND MEDICAL RESEARCH FUNDING WORKING GROUP (GRANTS REVIEW WORKING GROUP)
TO THE CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE

Organized Pursuant To The
CALIFORNIA STEM CELL RESEARCH AND CURES ACT

 
Date: Friday, February 9, 2009

Location:

Westin on Market
50 Third Street
San Francisco, CA
 

OPEN SESSION    

February 9, 8:00 am to 8:30 am

 

  1. Call to Order.
  2. Roll Call.
  3. Welcome & Chair's Comments
  4. Public Comment. Members of the public will be invited to provide testimony. Speakers are asked to limit their testimony to three (3) minutes
 

CLOSED SESSION

  1. Evaluation of RFA 08-05 Applications February 9, 8:30 am – 6:00pm
  2. Evaluation of RFA 08-05 Applications February 10, 8:30 am – 6:00pm
  3. Evaluation of RFA 08-05 Applications February 11, 8:30 am – 1:00pm
  4. Adjourn

Meetings of the Grants Review Working Group will be held in a public session format except for the review of individual grant applications which will be conducted in closed session.

THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE.
Notice is hereby given that the order of consideration of matters on this agenda may be changed without prior notice.

 


 

**NOTICE**

 

The California Institute for Regenerative Medicine and its Independent Citizens Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Meybel Cortez at the California Institute for Regenerative Medicine at 415-396-9132 no later than the day prior to the meeting.

Questions or requests for additional information prior to the Scientific & Medical Research Funding Working Group meeting may be referred to Dr. Gil Sambrano at the California Institute for Regenerative Medicine at gsambrano@cirm.ca.gov or 415-396-9103.

This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at www.cirm.ca.gov.

 

© 2013 California Institute for Regenerative Medicine